Durham biotech makes $78M deal for Philly firm to boost platform for cancer treatment
The Durham-based biopharmaceutical firm is aiming to boost its pipeline of drugs designed to combat recurrent glioma – a form of brain cancer.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Cameron Snipes Source Type: news
More News: American Health | Biotechnology | Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Glioma | Health Management | Neurology